Meridian Bioscience, Inc.
If you purchased Meridian Bioscience, Inc. securities and would like to join the action, please click "Join This Action" below.
VIVO STOCK ALERT: HALPER SADEH LLP IS INVESTIGATING WHETHER THE SALE OF MERIDIAN BIOSCIENCE, INC. IS FAIR TO SHAREHOLDERS
July 7, 2022.
New York, New York—Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Meridian Bioscience, Inc. (NASDAQ: VIVO) to SD Biosensor, Inc. and SJL Partners LLC for $34.00 per share in cash is fair to Meridian shareholders.
The investigation concerns whether Meridian and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Meridian shareholders; (2) determine whether SD Biosensor and SJL Partners are underpaying for Meridian; and (3) disclose all material information necessary for Meridian shareholders to adequately assess and value the merger consideration. On behalf of Meridian shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.